Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Item

http://www.wikidata.org/entity/Q33417569

Q33417569

about

Adjuvant chemotherapy for rectal cancer: Is it needed?Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy Pancreaticoduodenectomy for locally advanced colon cancer in hereditary nonpolyposis colorectal cancer Neoadjuvant treatment for rectal cancer-A value-based proposition.Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile?Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer.Mangafodipir a Selective Cytoprotectant - with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN)Bone marrow tolerance during postoperative chemotherapy in colorectal carcinomas.Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014 Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer.Advances and challenges in treatment of locally advanced rectal cancer.Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level: A Useful Tool for Prediction of Distant Metastasis in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective Chemoradiotherapy Evaluation of treatment response and tissue necrosis as prognostic indicators following neoadjuvant chemoradiotherapy in rectal cancer patients Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trial Is It Possible to Shorten the Duration of Adjuvant Chemotherapy for Locally Advanced Rectal Cancer?Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients.Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy.Interim analysis of postoperative chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone for pathological stage II and III rectal cancer: a randomized multicenter phase III trial.SEOM Clinical Guideline of localized rectal cancer (2016).Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: analysis on 1798 patients by prediction model.Pre- and post-surgery treatments in rectal cancer: a long-term single-centre experience.The clinicopathologic relevance and prognostic value of tumor deposits and the applicability of N1c category in rectal cancer with preoperative radiotherapy Recent advances in multidisciplinary approach for rectal cancer.Neoadjuvant treatment for locally advanced rectal cancer: a systematic review.The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer.Evaluating the addition of oxaliplatin to single agent fluoropyrimidine in the treatment of locally advanced rectal cancer: a systematic review and meta-analysis.Combination Adjuvant Chemotherapy with Targeted Drugs for Treatment of Colorectal Cancer: A Network Meta-Analysis.Controversies in the multimodality management of locally advanced rectal cancer.Update on advances and controversy in rectal cancer treatment.Rectal Cancer Surveillance-Recurrence Patterns and Survival Outcomes from a Cohort Followed up Beyond 10 Years.Adjuvant chemotherapy for rectal cancer: time to change the guidelines.Systemic capillary leak syndrome in a patient receiving adjuvant oxaliplatin for locally advanced colon cancer.MicroRNAs are important regulators of drug resistance in colorectal cancer.

P2860

Q26775099-04FC3445-0C59-4B43-84C9-9BA6F1A1EEA4 Q27004011-76FFF5EC-774E-498A-859C-55A814BF96FB Q28076357-966359A7-7723-43EF-83FD-6093361B713E Q30251516-9B02A679-D181-424C-B2F9-F014B57BA4D0 Q33432180-D7EEE971-23E4-4F86-8219-9A092C4557CE Q33776697-7C565C47-5D5C-4FBF-BAB8-38A0AA3C7A92 Q33798353-933E3416-7ACF-4E2D-9E46-1D70B3DEF76B Q33868520-C15112D3-FC6B-4D79-8661-D05BEFF6BC76 Q33895624-5EABF784-EFA7-4692-B843-6794F1CAE778 Q35445092-5A0B8290-67AF-4063-B8F3-F2DE3E52F7C8 Q35779456-41DB943F-16A2-4C68-ABFD-7FEF4EC0C413 Q36020920-A6E9B4BA-F59B-4DF2-A4D6-3041E6AAB3BD Q36025983-F5CCFD28-3D9D-4F0B-BF6A-F9A1EDCD6352 Q36194714-45261F2A-FC61-41E9-9074-4E52DB0C6EF9 Q36303226-BAE5B8E7-7543-446F-A7BD-27B72E15CA06 Q36445146-0C5425C1-77D1-449D-B269-61E11D81CA05 Q36461108-873164EA-E4A8-474C-A06F-3C3FAEC7D7F7 Q36557606-B6E9F629-6F64-4EF6-861A-451F249D9D80 Q36838083-DD68B9A2-DCFE-4C8E-BE79-A6B976B82F01 Q36853674-6FB13AF2-DEA4-485C-9281-64BE8499A158 Q36913615-C84C4A84-26CA-4857-B570-A4F5D19F5898 Q37041204-EB523C89-9CB2-4EA4-97F8-A2E01B94A694 Q37097565-CA5D18F6-5CB8-4FF9-AC0B-353F347C7165 Q37190135-3553FD94-7F6A-4438-A121-BE7381F836F6 Q37295422-147ACF10-3219-4DA6-A4D6-562FC2A1DD6F Q37475229-7EB7D8ED-9D55-4841-95AB-7443D1A2E47D Q37564794-A15DEF26-722E-45F2-A683-20402EBCB937 Q37672022-1E44BBD2-597A-4A50-AEEC-662B3FA2178C Q37688901-B3AD3D45-7604-4BBF-BE49-1F3749536AE3 Q38534726-3976D556-11BC-420B-9313-4490B3E5F9A8 Q38546385-5C7C412C-D344-42F0-8861-C222873A25D1 Q38587521-B46B2C11-B69B-4EEA-A381-F471D8FDA5FC Q38618772-810D1129-6706-4DDA-9E47-1DE2DB35A4E9 Q38644154-5C044B24-4CFB-44A4-96B1-9388C7908AD3 Q38691264-1E360901-B4D7-479A-AB0D-601573268932 Q38692803-14C5C4D5-F289-4F90-ADA7-185731E769B9 Q38703197-C3DD28C0-978D-40D0-9A39-B6547EF760A0 Q38728332-A5ED06C3-4F8E-4019-906F-67F79F86FBCE Q38996049-60624CD0-1F48-42A4-94AD-63277CE00006 Q39016759-F3140C08-AB05-43CB-ADF8-1C724067467B

P2860

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Item

http://www.wikidata.org/entity/Q33417569

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu